|
|
 |
|
Viewing report
|
|
|
|
2009 Chemicals, Pharmaceuticals, Medical Products & Biotechnology - UK Key Corporate Changes
Mandis Information Services Ltd, Aug 2009, Pages: 363
The Mandis 2009 Key Corporate Changes report for the UK Chemicals, Pharmaceuticals, Medical Products & Biotechnology Sector will put you ahead of your competition in terms of market knowledge. This is an in depth report detailing 304 key changes and developments, covering 196 different companies. These are the Key Corporate Changes that have occurred within or to the relevant market participants and that can be considered to have shaped and influenced the overall UK market during the year.
The report includes over 99 pages of Key Corporate Changes including:
- 61 changes driving Job Creation and highlighting growth companies,
- 58 changes giving rise to Redundancies, thus identifying companies that are shrinking and may be potential take-over targets.
- 36 product and service developments, which identifies those companies responding to significant changes within their marketplace by varying their product mix.
- 17 significant Administrations or Liquidations, these may give rise to opportunities for strong market players to cost effectively acquire new assets, staff and clients.
- 67 Major financial changes, which provides valuable market knowledge and insights into the impact on performance of the key players due to of current market forces.
This report is unique within the UK market, as it is the only sector report that is based upon the Key Corporate Changes that have driven change in the market and is completely up to date, as of the report date. The report condenses the details of those change events into brief summaries. These would therefore provide the perfect input to developing your own value added consultancy reports, allowing you to add depth and facts by including specific details of developments within individual companies. The report comprises two principal sections.
The first section consists of a one-line synopsis of every corporate change covered in the report. In this section, organisations with two or more change summaries have been grouped by organisation and indexed alphabetically by organisation name. Within organisation name, the summaries are listed in descending date order with the latest dated summary shown first. For organisations with only a single change summary in the report period, the information is grouped under Other Organisations and is shown in descending date order. The only exceptions to this being those summaries that are considered exceptionally important; these are then also shown under the separate organisation name in the index of organisations.
The second section comprises the detailed text of every event summary covered in the report, each of which is headed by the date and the organisation name. The information is grouped by the type of dynamic change covered by the event summary and is shown in descending date order within that section.
Customers who bought this item also bought
Gene Therapy - Global Strategic Business Report
A Quick Guide to Clinical Trials for People Who May Not Know It All
Top 450 Biotechnology (Pharmaceuticals) Report (Global)
Strategies for Building Biologics Capabilities and Franchises
Biotech Investment and Business Trends: Weathering the Economic Storm
Biotechnology Reagents - Global Strategic Business Report
Maven Semantic Healthcare Database (SME Package)
Proteomics - Global Strategic Business Report
Directory of Top 60 Biopharmaceutical Manufacturers in India
Nanobiotechnology - Global Strategic Business Report
|
|
|
|
